Prof. Michael Carrier testifies before House Energy & Commerce Committee

Prof. Carrier testified before the House Energy & Commerce Committee in support of legislation that would lower drug prices by targeting “pay-for-delay” settlements and citizen petitions. This was the second time he testified in Congress in the past week. https://energycommerce.house.gov/committee-activity/hearings/hearing-on-negotiating-a-better-deal-legislation-to-lower-the-cost-of

Prof. Michael Carrier testifies before House Judiciary Committee

Prof. Carrier testified before the House Judiciary Committee in support of antitrust legislation that would lower drug prices. He offered proposals on product hopping, pay-for-delay settlements, citizen petitions, biosimilar disparagement, and pharmaceutical mergers. In response to questioning from Rep. Hakeem Jeffries, Prof. Carrier discussed his work with Rutgers Law alum Carl Minniti on citizen petitions. … Continue reading Prof. Michael Carrier testifies before House Judiciary Committee

5th Circuit takes position Prof. Michael Carrier suggested in amicus brief

The Fifth Circuit today gave the FTC (and U.S. consumers) a huge win today in finding that Endo and Impax entered into a pay-for-delay settlement that delayed the entry of opioid Opana ER. The opinion reached the result suggested by Prof. Michael Carrier in his brief on behalf of 82 professors. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3504773 Link to opinion…